Steriscience Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STERISCIENCE, and what generic alternatives to STERISCIENCE drugs are available?
STERISCIENCE has thirty-three approved drugs.
There are two US patents protecting STERISCIENCE drugs.
There are two patent family members on STERISCIENCE drugs in two countries and eighty-five supplementary protection certificates in eleven countries.
Summary for Steriscience
| International Patents: | 2 |
| US Patents: | 2 |
| Tradenames: | 26 |
| Ingredients: | 23 |
| NDAs: | 33 |
Drugs and US Patents for Steriscience
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steriscience Speclts | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 091503-001 | Oct 18, 2011 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Steriscience Speclts | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 201025-002 | Apr 9, 2014 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Steriscience | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 217873-001 | Jul 9, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Steriscience Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 112243376 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2019221815 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Steriscience Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0806968 | SPC/GB07/011 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
| 2666774 | CA 2020 00037 | Denmark | ⤷ Subscribe | PRODUCT NAME: RELEBACTAM, OPTIONALLY IN THE FORM OF THE MONOHYDRATE, IMIPENEM AND CILASTATIN, OPTIONALLY IN THE FORM OF THE SODIUM SALT; REG. NO/DATE: EU/1/19/1420 20200217 |
| 1856135 | LUC00153 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: FOSTAMATINIB OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE FOSTAMATINIB, OU UN HYDRATE, SOLVATE OU N-OXYDE DE FOSTAMATINIB OU LE SEL PHARMACEUTIQUEMENT ACCEPTABLE DE FOSTAMATINIB, EN PARTICULIER FOSTAMATINIB DISODIUM, EVENTUELLEMENT SOUS FORME D'HYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/19/1405 20200113 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
